At Om, we're redefining medicine discovery by removing the bespoke slog everyone traditionally faces. We're giving universal access to comprehensive, proteome-wide interaction data involving hundreds of millions of molecules. Leveraging advanced synthetic biology, pico-scale droplet engineering, and next-generation sequencing, our platform rapidly generates massive multiplexed datasets, unlocking powerful therapeutic insights faster than ever before.
We wanted to build the company we wished existed.
Devon Cayer
Traditional medicine discovery is notoriously slow, costly, and risky—taking 10-15 years and billions of dollars to bring a single drug to market, with over 90% of candidates failing during clinical trials. These failures often stem from inadequate early-stage data, unforeseen off-target effects, and insufficient molecular specificity. Om's groundbreaking platform directly addresses these critical challenges by preemptively screening entire proteomes against extensive molecular libraries, dramatically accelerating the discovery timeline from months to mere weeks.
Through our API, researchers and teams of all sizes gain seamless integration of vast datasets and sophisticated predictive AI directly into their workflows. Our team combines deep technical expertise in genomics, chemical biology, machine learning, and ultra-high throughput sequencing, driven by firsthand experience tackling the same discovery bottlenecks the industry faces today. Om stands at the forefront, democratizing access to critical data, streamlining medicine discovery, and rapidly delivering transformative treatments to patients worldwide.
